Effects of filament B knockdown on proliferation, migration and apoptosis of mouse MC3T3-E1 cells

doi:10.12307/2024.516

Abstract

Abstract: BACKGROUND: Filamin B (FLNB) can crosslink the actin cytoskeleton into a dynamic structure that is essential for the directional movement of cells. It can regulate the proliferation, differentiation and apoptosis of chondrocytes. However, the effect of FLNB on osteoblast proliferation, migration and apoptosis has not been reported.
OBJECTIVE: To investigate the effect of FLNB on the proliferation, migration and apoptosis of MC3T3-E1 cells.
METHODS: The adenoviral vectors for knockdown of FLNB expression (sh-FLNB1, sh-FLNB2, sh-FLNB3) were constructed and infected with MC3T3-E1 cells. After screened by puromycin drug, the efficiency of FLNB knockdown was detected by western blot and RT-PCR. The MC3T3-E1 cell line with the best efficiency of FLNB knockdown was selected as the stable transient cell line of MC3T3-E1 for subsequent experiments. The cells were divided into blank group, mc3t3 group, sh-NC group (empty vector), and sh-FLNB group (sh-FLNB lentivirus). The blank group was cultured in cell-free α-MEM complete medium; the mc3t3 group was cultured in α-MEM complete medium alone; and the sh-NC and sh-FLNB groups were cultured with α-MEM medium containing 2.5 μg/mL puromycin. After 3 days of culture, cell counting kit-8 assay and cell scratch assay were used to detect the proliferation and migration ability of MC3T3-E1; flow cytometry was used to detect cell apoptosis; and RT-PCR was used to detect the expression of apoptosis-related genes.
RESULTS AND CONCLUSION: Western blot and RT-PCR results showed that the efficiency of FLNB knockdown was the best in the sh-FLNB3 (P < 0.000 1), which was used as a stable cell line for subsequent experiments. Cell counting kit-8 data showed that the proliferative ability of MC3T3 cells was significantly weakened after knockdown of FLNB (P < 0.05). Cell scratch assay results showed that the migration ability of MC3T3 cells was significantly decreased after knockdown of FLNB. Flow cytometry and RT-PCR results showed that the apoptotic rate of MC3T3-E1 cells increased after knockdown of FLNB, the expression of pro-apoptotic factor Bax increased significantly, and the expression of anti-apoptotic factor Bcl-2 decreased significantly (P < 0.05). To conclude, knockdown of FLNB can reduce the proliferation ability of MC3T3-E1 cells, decrease the migration ability of the cells, and increase cell apoptosis.

Key words: Filamin B, MC3T3-E1, proliferation, migration, apoptosis

CLC Number:

Wang Xi, Yu Li, Jia Qiyu, Huang Jinyong, Liu Zebiao, Zhang Jun, Jiayidaer•Dilimulati, Xie Zengru, Ma Hairong. Effects of filament B knockdown on proliferation, migration and apoptosis of mouse MC3T3-E1 cells[J]. Chinese Journal of Tissue Engineering Research, 2024, 28(32): 5177-5181.

Figures/Tables 4

References

[1] 中华医学会骨质疏松和骨矿盐疾病分会. 中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019, 12(4):317-318.
[2] KHOSLA S, HOFBAUER LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017;5(11):898-907.
[3] TSAI JN, LEE H, DAVID NL, et al. Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial. Lancet Diabetes Endocrinol. 2019;7(10):767-775.
[4] ENSRUD KE, CRANDALL CJ. Osteoporosis. Ann Intern Med. 2017;167(3):ITC17-ITC32.
[5] COSMAN F, CRITTENDEN DB, ADACHI JD, et al. Romosozumab Treatment in Postmenopausal Women with Osteoporosis. N Engl J Med. 2016;375(16):1532-1543.
[6] KAVEH S, HOSSEINIFARD H, GHADIMI N, et al. Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis. Clin Rheumatol. 2020;39(11):3261-3276.
[7] ZHOU AX, HARTWIG JH, AKYUREK LM. Filamins in cell signaling, transcription and organ development. Trends Cell Biol. 2010;20(2):113-123.
[8] STOSSEL TP, CONDEELIS J, COOLEY L, et al. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2001;2(2):138-145.
[9] GORLIN JB, YAMIN R, EGAN S, et al. Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring. J Cell Biol. 1990;111(3): 1089-1105.
[10] 宋蕊, 张鑫悦, 周红辉,等. FLNB突变致胎儿期拉森综合征的遗传学研究[J]. 解放军医学院学报,2021,42(5):560-564.
[11] LI GH, KUNG AW, HUANG QY. Common variants in FLNB/CRTAP, not ARHGEF3 at 3p, are associated with osteoporosis in southern Chinese women. Osteoporos Int. 2010;21(6):1009-1020.
[12] WILSON SG, JONES MR, MULLIN BH, et al. Common sequence variation in FLNB regulates bone structure in women in the general population and FLNB mRNA expression in osteoblasts in vitro. J Bone Miner Res. 2009;24(12):1989-1997.
[13] 贾麒钰, 黄晓夏, 郭建,等. 整合素靶向肽促进SD大鼠骨髓间充质干细胞的增殖[J]. 中国组织工程研究,2022,26(30):4780-4786 .
[14] HU J, LU J, LIAN G, et al. Filamin B regulates chondrocyte proliferation and differentiation through Cdk1 signaling. PLoS One. 2014;9(2):e89352.
[15] ZIEBA J, ZHANG W, CHONG JX, et al. A postnatal role for embryonic myosin revealed by MYH3 mutations that alter TGFβ signaling and cause autosomal dominant spondylocarpotarsal synostosis. Sci Rep. 2017:7:41803.
[16] SU YT, GAO C, LIU Y, et al. Monoubiquitination of filamin B regulates vascular endothelial growth factor-mediated trafficking of histone deacetylase 7. Mol Cell Biol. 2013;33(8):1546-1560.
[17] FUKUSHIMA K, PARTHASARATHY P, WADE EM, et al. Intragenic Deletions in FLNB Are Part of the Mutational Spectrum Causing Spondylocarpotarsal Synostosis Syndrome. Genes (Basel). 2021;12(4):528.
[18] VAN DER FLIER A, KUIKMAN I, KRAMER D, et al. Different splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin [beta] subunits. J Cell Biol. 2002;156(2):361-376.
[19] ZHANG W, HAN SW, MCKEEL DW, et al. Interaction of presenilins with the filamin family of actin-binding proteins. J Neurosci. 1998;18(3):914-922.
[20] 王茜, 颜举, 黄金勇,等. FilaminB在骨骼系统中的研究进展[J]. 中国骨质疏松杂志,2023,29(4):606-610.
[21] LU J, LIAN G, LENKINSKI R, et al. Filamin B mutations cause chondrocyte defects in skeletal development. Hum Mol Genet. 2007;16(14):1661-1675.
[22] 黄金勇, 吐尔逊江•达地汗, 郑靖杰, 等. 鹰嘴豆芽异黄酮对小鼠成骨前体细胞MC3T3-E1增殖及分化的研究[J]. 中国骨质疏松杂志,2022,28(12): 1723-1727,1734.
[23] JING WB, JI H, JIANG R, et al. Astragaloside positively regulated osteogenic differentiation of pre-osteoblast MC3T3-E1 through PI3K/Akt signaling pathway. J Orthop Surg Res. 2021;16(1):579.
[24] VAN DER FLIER A, SONNENBERG A. Structural and functional aspects of filamins. Biochim Biophys Acta. 2001;1538(2-3):99-117.
[25] AYSCOUGH KR. In vivo functions of actin-binding proteins. Curr Opin Cell Biol. 1998;10(1):102-111.
[26] SIDDIQUI JA, PARTRIDGE NC. Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. Physiology (Bethesda). 2016;31(3):233-245.
[27] GEORGES S, RUIZ VELASCO C, TRICHET V, et al. Proteases and bone remodelling. Cytokine Growth Factor Rev. 2009;20(1):29-41.
[28] SALHOTRA A, SHAH HN, LEVI B, et al. Mechanisms of bone development and repair. Nat Rev Mol Cell Biol. 2020;21(11):696-711.
[29] WEIVODA MM, BRADLEY EW. Macrophages and Bone Remodeling. J Bone Miner Res. 2023;38(3): 359-369.
[30] XU X, LAI Y, HUA ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2019;39(1):BSR20180992.
[31] JIANG Y, ZHANG P, ZHANG X, et al. Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis. Cell Prolif. 2021;54(1):e12956.
[32] LI Z, LI D, CHEN R, et al. Cell death regulation: A new way for natural products to treat osteoporosis. Pharmacol Res. 2023;187:106635.